Adagio Medical Holdings, Inc. (ADGM) - 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated November 12, 2025, reports the issuance of a press release containing financial results for the quarter ended September 30, 2025, and a business update. The Company is an emerging growth company incorporated in Delaware with its principal executive offices in Laguna Hills, CA.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period. Investors must refer to the referenced press release (Exhibit 99.1) for comparative financial analysis.
Guidance, Outlook, and Risks
The Company provided a business update alongside the financial results, though specific guidance or outlook figures are not included in this filing text. The filing includes a standard disclaimer that the information furnished under Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 12, 2025) for actual revenue, net income, and cash flow figures for the quarter ended September 30, 2025.
- Verify the specific details of the "business update" mentioned in Item 2.02 to understand operational changes.
- Confirm the Company's status as an emerging growth company and any implications for financial reporting standards.
- Check the Nasdaq Stock Market for any subsequent trading halts or announcements related to the release.